OxTalks is Changing
OxTalks will soon move to the new Halo platform and will become 'Oxford Events.' There will be a need for an OxTalks freeze. This was previously planned for Friday 14th November – a new date will be shared as soon as it is available (full details will be available on the Staff Gateway).
In the meantime, the OxTalks site will remain active and events will continue to be published.
If staff have any questions about the Oxford Events launch, please contact halo@digital.ox.ac.uk
Characterisation of alloantigens and their cognate T cell responses in Acute Myeloid Leukaemia. Implications For A Novel Approach To TCR Therapy
Paresh Vyas is a clinical academic and Deputy Director of the MRC Molecular Haematology Unit (MHU), Weatherall Institute of Molecular Medicine (WIMM) at the University of Oxford. He is clinical lead for AML (Acute Myeloid Leukaemia) and MDS (Myelodysplasia) for Oxford and leads Phase I-III clinical trials in the UK and international in AMl and MDS. His research focuses on allo-immune responses to leukemia and the molecular and cellular biology of normal and leukaemic haemopoiesis.
Date:
28 March 2023, 9:30
Venue:
Wellcome Trust Centre for Human Genetics, Headington OX3 7BN
Venue Details:
Room A&B
Speaker:
Professor Paresh Vyas (University of Oxford, Weatherall Institute of Molecular Medicine)
Organising department:
CAMS Oxford Institute
Organiser contact email address:
coi.admin@ndm.ox.ac.uk
Hosts:
Prof Tao Dong (CAMS Oxford Institute, University of Oxford),
Dr Ricardo Fernandes (CAMS Oxford Institute, University of Oxford)
Part of:
CAMS Oxford Institute Seminars
Booking required?:
Not required
Audience:
Members of the University only
Editor:
Natalie Baker
